OOIR: Observatory of International Research

Papers

(The H4-Index of Advanced Drug Delivery Reviews is 85. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)

Article	Citations
Cell membrane-coated nanoparticles for targeting carcinogenic bacteria	719
Editorial board members	382
Emerging antibiotic alternatives: From antimicrobial peptides to bacteriophage therapies	300
Penetration and translocation of functional inorganic nanomaterials into biological barriers	300
Long-acting inhaled medicines: Present and future	299
Gene editing strategies to treat lysosomal disorders: The example of mucopolysaccharidoses	288
Nanoparticle-neutrophils interactions for autoimmune regulation	261
MIDD in Japan– Implementations, challenges and opportunities	246
Genome-scale metabolic modelling in antimicrobial pharmacology: Present and future	245
Integrating microneedles and sensing strategies for diagnostic and monitoring applications: The state of the art	236
Polymer-based drug delivery systems under investigation for enzyme replacement and other therapies of lysosomal storage disorders	195
Leveraging the neurosurgical operating room for therapeutic development in NeuroOncology	193
Liposomal formulations for treating lysosomal storage disorders	193
Therapeutic and delivery strategies of phytoconstituents for renal fibrosis	177
Deciphering albumin-directed drug delivery by imaging	172
Progress on the pathological tissue microenvironment barrier-modulated nanomedicine	165
Luminescent quantum dots: Synthesis, optical properties, bioimaging and toxicity	158
Recent advances in endocrine organoids for therapeutic application	153
Nanovaccines with cell-derived components for cancer immunotherapy	151
Tools for computational design and high-throughput screening of therapeutic enzymes	147
MicroRNAs and their delivery in diabetic fibrosis	146
Drug delivery for metabolism targeted cancer immunotherapy	144
Bacterially mediated drug delivery and therapeutics: Strategies and advancements	143
Opportunities and challenges in delivering biologics for Alzheimer’s disease by low-intensity ultrasound	142
Emerging strategies to bypass transplant rejection via biomaterial-assisted immunoengineering: Insights from islets and beyond	137

Drug delivery strategies in maximizing anti-angiogenesis and anti-tumor immunity	134
Models to study basic and applied aspects of lysosomal storage disorders	133
Nanoparticle designs for delivery of nucleic acid therapeutics as brain cancer therapies	133
Design, development and clinical translation of CriPec®-based core-crosslinked polymeric micelles	132
Emerging Voices in Drug Delivery – Harnessing and Modulating Complex Biological Systems (Issue 2)	132
Editorial Board	131
From cells to subcellular organelles: Next-generation cancer therapy based on peptide self-assembly	131
3D printing of drug delivery systems enhanced with micro/nano-technology	131
Editorial/Preface	130
Protein encapsulation of nanocatalysts: A feasible approach to facilitate catalytic theranostics	129
Strategies to develop polymeric microneedles for controlled drug release	127
Novel strategies for modulating the gut microbiome for cancer therapy	123
Biomarker and therapeutic potential of peripheral extracellular vesicles in Alzheimer’s disease	122
Activatable dual-functional molecular agents for imaging-guided cancer therapy	119
Solid implantable devices for sustained drug delivery	119
In situ cellular hitchhiking of nanoparticles for drug delivery	118
RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer	117
Drug development of lyso-thermosensitive liposomal doxorubicin: Combining hyperthermia and thermosensitive drug delivery	116
In vitro-in vivo correlation of cascade impactor data for orally inhaled pharmaceutical aerosols	115
Synthetic biology-guided design and biosynthesis of protein polymers for delivery	113
Nanoparticles-mediated ion channels manipulation: From their membrane interactions to bioapplications	112
Targeting microbiome, drug metabolism, and drug delivery in oncology	112
Activatable fluorescent probes for real-time imaging-guided tumor therapy	111
Exosome- and extracellular vesicle-based approaches for the treatment of lysosomal storage disorders	110
Ultrasonic particles: An approach for targeted gene delivery	109
Drug delivery using gold nanoparticles	108
Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers	108
Pulmonary delivery nanomedicines towards circumventing physiological barriers: Strategies and characterization approaches	105
Biopharmaceutical drug delivery and phototherapy using protein crystals	105
Antibody-drug conjugates as multimodal therapies against hard-to-treat cancers	100
Light sheet fluorescence microscopy for monitoring drug delivery: Unlocking the developmental phases of embryos	100
Technological and translational challenges for extracellular vesicle in therapy and diagnosis	99
Unignored intracellular journey and biomedical applications of extracellular vesicles	99
Emerging drug delivery systems with traditional routes – A roadmap to chronic inflammatory diseases	99
Hurdles in translating science from lab to market in delivery systems for Cosmetics: An industrial perspective	98
Nanosensitizer-mediated unique dynamic therapy tactics for effective inhibition of deep tumors	98
Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies	98
Miniaturized therapeutic systems for ultrasound-modulated drug delivery to the central and peripheral nervous system	97
Novel drug delivery systems for the management of dry eye	95
Tumour extravasation of nanomedicine: The EPR and alternative pathways	95
Convection-enhanced delivery for brain malignancies: Technical parameters, formulation strategies and clinical perspectives	94
Micro-patterned cell populations as advanced pharmaceutical drugs with precise functional control	94
Lysosomal therapies and drug delivery strategies: An overview	93
Soft nano and microstructures for the photomodulation of cellular signaling and behavior	92
Engineering bacterial membrane nanovesicles for improved therapies in infectious diseases and cancer	92
In-vitro 3D modelling for charged particle therapy – Uncertainties and opportunities	91
Modular design principle based on compartmental drug delivery systems	90
The extracellular matrix of hematopoietic stem cell niches	90
Model-informed precision dosing: State of the art and future perspectives	90
Nanobodies: Robust miniprotein binders in biomedicine	89

To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives	88
Drug delivery strategies for management of women’s health issues in the upper genital tract	88
Fit and forget: The future of dental implant therapy via nanotechnology	88
Lipid nanoparticles for targeted delivery of anticancer therapeutics: Recent advances in development of siRNA and lipoprotein-mimicking nanocarriers	88
Advances in photoactivated carbon-based nanostructured materials for targeted cancer therapy	87
Corrigendum to “Editorial: Advanced strategies to bridge the gap between inflammation and tissue regeneration” [Adv. Drug Deliv. Rev. 209 (2024) 115328]	86
Engineering complexity in human tissue models of cancer	86
Preface: Image-assisted organoid research and application	86
Gelatin-integrated carbon nanomaterials in nanomedicine: From biosensing and bioprinting to tissue engineering and other biomedical applications	85
Editorial Board	85
Oral nanomedicine biointeractions in the gastrointestinal tract in health and disease	85